Alkermes is a biotech company taking on mental illness, and it’s up 30% this year. So, can Alkermes CEO Richard Pops keep the healthy gains coming?
source CNBC
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More